The main morning developments included a rebound in NATTY HD, a sharp surge in TWOSTONE, a decline in ユニシア HD, a continued decline in ステラファーマ, a decline in TSIHD, and ステムリム's registration of a US patent.
NATTY S reported that its September same-store sales rose 3.4% year on year, while customer numbers fell 5.4% and average spend per customer rose 9.3%. The company’s sales across all stores rose 3.5%, prompting a rebound in the share price.
ツーストーン announced that a group company had formed a business partnership with Layer8 and would enter the AI-powered web security market. As its first offering, the company will begin providing penetration testing for web applications and APIs.
ユニシア HD announced that 串カツ田中グループ's September same-store sales rose 3.0% year on year. Customer numbers rose 1.5%, average spend per customer rose 1.5%, and sales across all stores rose 20.2%.
ステラファーマ announced that an additional indication for Steboronin for recurrent meningioma was scheduled to be reviewed by the Pharmaceutical Affairs Council, and the share price continued to decline. Although data including two-year survival indicators were presented, the impact on the share price was limited.
TSI Holdings reported that September same-store sales rose 9.0% year on year, while sales across all stores also rose 9.0%. Sales of early-autumn merchandise contributed, and e-commerce growth was also relatively strong.
ステムリム announced that a US patent had been registered for SR-GT1, its gene therapy candidate for dystrophic epidermolysis bullosa. The technology introduces a normal type VII collagen gene into patient-derived mesenchymal stem cells, and the company is advancing manufacturing support for clinical trial products.